Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
Nat Commun. 2022 May 26;13(1):2956. doi: 10.1038/s41467-022-30580-5.
The Omicron SARS-CoV-2 has several distinct sublineages, among which sublineage BA.1 is responsible for the initial Omicron surge and is now being replaced by BA.2 worldwide, whereas BA.3 is currently at a low frequency. The ongoing BA.1-to-BA.2 replacement underscores the importance to understand the cross-neutralization among the three Omicron sublineages. Here we test the neutralization of BA.1-infected human sera against BA.2, BA.3, and USA/WA1-2020 (a strain isolated in late January 2020). The BA.1-infected sera neutralize BA.1, BA.2, BA.3, and USA/WA1-2020 SARS-CoV-2s with geometric mean titers (GMTs) of 445, 107, 102, and 16, respectively. Thus, the neutralizing GMTs against heterologous BA.2, BA.3, and USA/WA1-2020 are 4.2-, 4.4-, and 28.4-fold lower than the GMT against homologous BA.1, respectively. These findings have implications in COVID-19 vaccine strategy.
奥密克戎 SARS-CoV-2 有几个不同的亚谱系,其中亚谱系 BA.1 是最初奥密克戎浪潮的罪魁祸首,现在正在全球范围内被 BA.2 取代,而 BA.3 目前频率较低。正在进行的 BA.1 到 BA.2 的取代强调了理解三种奥密克戎亚谱系之间交叉中和的重要性。在这里,我们测试了 BA.1 感染的人类血清对 BA.2、BA.3 和 USA/WA1-2020(2020 年 1 月下旬分离的菌株)的中和作用。BA.1 感染的血清对 BA.1、BA.2、BA.3 和 USA/WA1-2020 SARS-CoV-2 的中和几何平均滴度(GMT)分别为 445、107、102 和 16。因此,针对异源 BA.2、BA.3 和 USA/WA1-2020 的中和 GMT 分别比同源 BA.1 的 GMT 低 4.2、4.4 和 28.4 倍。这些发现对 COVID-19 疫苗策略有影响。